PANCREATIC CANCER NEWS TIPS & FEATURES


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s Pamrevlumab. FG-3019 News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Preliminary Results Suggest That Pamrevlumab is Promising in Pancreatic Cancer

March 2, 2017

Preliminary Results Suggest That Pamrevlumab is Promising in Pancreatic Cancer

By Anonymous User anonymous_user_10987

Updated results from an ongoing clinical study of pamrevlumab (FG-3019) in combination with standard-of-care chemotherapy in patients with locally advanced pancreatic ductal adenocarcinoma were presented during the ASCO 2017 Gastrointestinal Cancers Symposium in San Francisco and appear to suggest pamrevulmab may improve outcomes compared to chemotherapy alone. About Pancreatic Ductal Adenocarcinoma and Connective Tissue Growth […]

View full entry

Tags: connective tissue growth factor, News Tips and Features, News Tips and Features Other, Pamrevlumab. FG-3019, Pancreatic Cancer


View more articles like this
More news and in-depth Pancreatic Cancer information

CONDITIONS OF THE GI TRACT